我国糖尿病流行病学和疾病经济负担研究现状

Current Status of Epidemic and Economic Burden of Diabetes Mellitus in China

目的:回顾我国糖尿病的患病率、死亡率和并发症及其疾病负担的现况与影响因素。方法:检索PUBMED和CBM中1994—2007年发表的涉及我国糖尿病流行病学和经济学内容的文献。结果:近年来糖尿病的患病率和死亡率出现增高的趋势,发病年龄年轻化,各系统并发症患病率高。糖尿病及其并发症的患病率和死亡率存在城乡、年龄、疾病病程和病情的差异。糖尿病直接医疗费以年均19.90%的速度增长,超过同期GDP以及全国卫生总费用的增长。其中,门诊和住院费占很大比重,特别是住院费的增长较为显著。并发症成为影响糖尿病经济负担的主要因素。结论:我国糖尿病不断增长的患病率和经济负担应当引起全社会的关注,政府部门在进行卫生资源分配时应充分考虑到糖尿病及其并发症造成的沉重的疾病负担。

Objective To investigate the prevalence, mortality, and the economic burden of diabetes and its complications as well as their influential factors in China. Method literatures published in PUBMED and CBM （Chinese Biological Medicine on disc） between 1994 and 2007 about epidemic and cost of type 2 diabetes （T2D） in China are identified. Results Prevalence of diabetes increases dramatically in recent decades, especially in 20-29 age group. Prevalence is higher in the elderly residents living in urban with longer duration of diabetes. Direct medical cost of T2D and complications increases at annual rate of 19.90% in recent years, which is higher than that of GDP and national healthcare expenditure growth. Costs of hospitalization and outpatient account for 91.90% of direct medical cost in China, among which hospitalization cost is rising significantly. Much of the economic burden is due to the development of micro-and macrovascular complications. Conclusions The increasing prevalence and cost of diabetes in China should arouse public awareness. Policy makers should consider the heavy burden of diabetes and its complications when setting priority to allocate limited health resources in China.